Subscribe To
CELU / After Plunging -38.63% in 4 Weeks, Here's Why the Trend Might Reverse for Celularity, Inc. (CELU)
CELU News
By Zacks Investment Research
March 17, 2023
Celularity, Inc. (CELU) Is a Trending Stock: Facts to Know Before Betting on It
Celularity, Inc. (CELU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can imp more_horizontal
By Zacks Investment Research
February 20, 2023
Here is What to Know Beyond Why Celularity, Inc. (CELU) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Celularity, Inc. (CELU). This makes it worthwhile to examine what the stock has in store more_horizontal
By Zacks Investment Research
February 8, 2023
Celularity, Inc. (CELU) is Attracting Investor Attention: Here is What You Should Know
Celularity, Inc. (CELU) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can imp more_horizontal
By Zacks Investment Research
January 24, 2023
Celularity, Inc. (CELU) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Celularity, Inc. (CELU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's more_horizontal
By Zacks Investment Research
January 11, 2023
Investors Heavily Search Celularity, Inc. (CELU): Here is What You Need to Know
Zacks.com users have recently been watching Celularity, Inc. (CELU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's more_horizontal
By Zacks Investment Research
January 9, 2023
After Plunging -38.63% in 4 Weeks, Here's Why the Trend Might Reverse for Celularity, Inc. (CELU)
Celularity, Inc. (CELU) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined wit more_horizontal
By Zacks Investment Research
December 23, 2022
Down 29.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Celularity, Inc. (CELU)
Celularity, Inc. (CELU) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement more_horizontal
By Zacks Investment Research
December 20, 2022
All You Need to Know About Celularity, Inc. (CELU) Rating Upgrade to Strong Buy
Celularity, Inc. (CELU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Stro more_horizontal